Revenue was down 7 percent, mainly due to lower volumes and divestments. Weaker European end markets and production issues in the Specialty Chemicals value chain adversely impacted our results, with operating income 8 percent lower at €217 million. Cash from operating activities improved €298 million, mainly due to lower pension payments.
Summary of financial outcomes
|
1st quarter |
|
| ||||
|
in € millions |
2012 |
2013 |
Δ% | |||
|
Revenue |
3,707 |
3,465 |
(7) | |||
|
Operating income |
236 |
217 |
(8) | |||
|
ROS% |
6.4 |
6.3 |
| |||
|
|
|
|
| |||
|
Invested capital |
12,519 |
10,484 |
| |||
|
Moving average ROI (in %) |
9.4 |
7.8 |
| |||
|
|
|
|
| |||
|
EBITDA |
410 |
375 |
(9) | |||
|
Capital expenditures |
135 |
131 |
| |||
|
Net cash from operating activities |
(704) |
(406) |
| |||
|
Net debt |
2,860 |
2,888 |
| |||
|
|
|
|
| |||
|
Net income from continuing operations |
110 |
96 |
(13) | |||
|
Net income from discontinued operations |
(26) |
(7) |
| |||
|
Net income attributable to shareholders |
84 |
89 |
6 | |||
|
Earnings per share from continuing operations (in €) |
0.47 |
0.40 |
| |||
|
Earnings per share from total operations (in €) |
0.36 |
0.37 |
| |||
|
Adjusted earnings per share (in €) |
0.65 |
0.51 |
| |||
|
Number of employees |
52,550 |
50,320 |
| |||